Biotechnology Stocks I Performance Guide: NewAmsterdam Pharma Company N.V. (NAMS)
NAMS has no dividends.
Table and Chart of NAMS Performance
See what a $1,000 investment in NAMS is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| NAMS Returns | |
|---|---|
| Start Date | Dec-30-2022 |
| Start Price | $10.90 |
| End Date | May-08-2024 |
| End Price | $21.79 |
| # Prices | 18 |
| Min Date | Oct-31-2023 |
| Min Price | $9.00 |
| Max Date | Mar-28-2024 |
| Max Price | $23.65 |
| Total Return | 99.91% |
| Annualized Return | 58.69% |
| Current Value of $1,000 Purchase | $1,999 |
| Number Returns | 153 |
| Average Return | 34.74% |
| Number Profitable Returns | 91 |
| Percent Profitable Returns | 59.48% |
| Number Unprofitable Returns | 62 |
| Percent Unprofitable Returns | 40.52% |
| Profitable to Unprofitable Returns Ratio | 1.47 |
| NAMS Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,981,750,000 |
| Beta | 0.022 | Price to Sales | 124.81 |
| Earnings per Share | $-2.1500 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 6.13 |
| PRICE DATA | |
| 52 Week High | $26.35 |
| 52 Week Low | $5.63 |
| Analyst Target Price | $34.71 |
| 50-Day Moving Average | $21.61 |
| 200-Day Moving Average | $14.47 |
| FINANCIAL DATA | |
| Revenue per Share | $0.171 |
| Revenue | $14,090,000 |
| Profit Margin | 0% |
| Return on Equity | -49.3% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
NAMS Compare Returns with S&P 500
NAMS Trendline Chart
NAMS Moving Average Chart
NAMS Stock Return Map - See Patterns of Gains and Losses
NAMS Stock Returns/Purchase Dates